Wells Fargo & Company Cue Biopharma, Inc. Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 20,077 shares of CUE stock, worth $20,277. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,077

Previous 20,077 -0.0%

Holding current value

$20,277

Previous $15,000 33.33%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$0.45 - $1.08 $272 - $654	-606 Reduced 2.93%	20,077 $15,000
Q2 2024 Aug 13, 2024	SELL	$1.24 - $2.18 $12,654 - $22,246	-10,205 Reduced 33.04%	20,683 $25,000
Q1 2024 May 10, 2024	BUY	$1.77 - $3.09 $2,594 - $4,529	1,466 Added 4.98%	30,888 $58,000
Q4 2023 Feb 09, 2024	SELL	$1.72 - $3.1 $83,870 - $151,162	-48,762 Reduced 62.37%	29,422 $77,000
Q3 2023 Nov 13, 2023	BUY	$2.23 - $4.69 $19,231 - $40,446	8,624 Added 12.4%	78,184 $179,000
Q2 2023 Aug 15, 2023	BUY	$3.11 - $4.91 $56,707 - $89,528	18,234 Added 35.53%	69,560 $253,000
Q1 2023 May 12, 2023	BUY	$2.41 - $3.74 $7,724 - $11,986	3,205 Added 6.66%	51,326 $183,000
Q4 2022 Feb 13, 2023	BUY	$2.39 - $3.95 $67,185 - $111,038	28,111 Added 140.48%	48,121 $137,000
Q3 2022 Nov 14, 2022	BUY	$2.23 - $3.37 $44 - $67	20 Added 0.1%	20,010 $45,000
Q2 2022 Aug 12, 2022	BUY	$2.49 - $5.92 $28,109 - $66,830	11,289 Added 129.74%	19,990 $50,000
Q1 2022 May 16, 2022	SELL	$4.41 - $12.28 $39,451 - $109,856	-8,946 Reduced 50.69%	8,701 $43,000
Q4 2021 Feb 14, 2022	BUY	$10.86 - $17.85 $180,786 - $297,148	16,647 Added 1664.7%	17,647 $200,000
Q2 2021 Aug 16, 2021	SELL	$10.9 - $14.53 $69,116 - $92,134	-6,341 Reduced 86.38%	1,000 $12,000
Q1 2021 May 13, 2021	SELL	$11.2 - $16.09 $507,091 - $728,490	-45,276 Reduced 86.05%	7,341 $89,000
Q4 2020 Feb 09, 2021	SELL	$11.12 - $16.4 $1,823 - $2,689	-164 Reduced 0.31%	52,617 $658,000
Q3 2020 Nov 05, 2020	SELL	$15.05 - $23.54 $44,909 - $70,243	-2,984 Reduced 5.35%	52,781 $795,000
Q2 2020 Aug 13, 2020	BUY	$12.7 - $30.73 $227,368 - $550,159	17,903 Added 47.28%	55,765 $1.37 Million
Q1 2020 May 14, 2020	BUY	$9.85 - $22.27 $372,940 - $843,186	37,862 New	37,862 $537,000

Others Institutions Holding CUE

# of Institutions

Shares Held

11.9M

Call Options Held

22K

Put Options Held

1.2K

View Full List

About Cue Biopharma, Inc.

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $35.7M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

More about CUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Cue Biopharma, Inc. Transaction History